Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned

Genetics
K E StrunkD W Threadgill

Abstract

The timing of lethality caused by homozygosity for a null allele of the epidermal growth factor receptor (Egfrtm1Mag) in mice is strongly dependent on genetic background. Initial attempts to genetically map background modifiers using Swiss-derived, outbred CD-1 mice were unsuccessful. To investigate the genetic architecture contributing to survival of Egfrtm1Mag homozygous embryos, the genetic variability segregating within the outbred population was partitioned by surveying viability of Egfrtm1Mag mutants using intercrosses between 129S6/SvEvTAC-Egfrtm1Mag and nine Swiss-derived, inbred strains: ALR/LtJ, ALS/LtJ, APN, APS, ICR/HaRos, NOD/LtJ, NON/LtJ, SJL/J, and SWR/J. The observations showed that these strains support varying levels of survival of Egfrtm1Mag homozygous embryos, suggesting that genetic heterogeneity within the CD-1 stock contributed to the original lack of Egfrtm1Mag modifier detection. Similar to the Swiss-derived intercrosses, nine congenic strains, derived from 129S6/SvEvTAC, AKR/J, APN, BALB/cJ, BTBR-T+ tf/tf, C3H/HeJ, C57BL/6J, DBA/2J, and FVB/NJ inbred backgrounds, also supported varying levels of survival of Egfrtm1Mag mutants. By intercrossing the congenic lines to create hybrid F1 embryos, different g...Continue Reading

References

Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·F CiardielloD S Salomon
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·K J FowlerJ A Danks
Mar 31, 1995·The Journal of Biological Chemistry·H ToyodaK Hanada
Mar 1, 1994·The Journal of Clinical Investigation·C FondacciD Evain-Brion
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O DassonvilleG Milano
Mar 12, 1993·Science·Y ShingJ Folkman
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·C M PerouD Botstein
Dec 30, 1999·Nature Genetics·J A BeckE M Fisher
Aug 6, 2000·Gynecologic Oncology·K S TewariJ P Fruehauf
Dec 5, 2000·International Journal of Cancer. Journal International Du Cancer·Y UmekitaH Yoshida
Mar 30, 2001·The Journal of Biological Chemistry·L StrachanK D Kumble
Jun 22, 2001·Trends in Genetics : TIG·R C Jansen, J P Nap
Nov 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·M L Wayne, L M McIntyre
Jun 19, 2003·Journal of the National Cancer Institute·Viktor Grünwald, Manuel Hidalgo
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Mendelsohn, Jose Baselga

❮ Previous
Next ❯

Citations

Jan 20, 2012·Nature Reviews. Cancer·Kent W Hunter
Nov 8, 2008·Science·Joseph S TakahashiVivek Kumar
May 19, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Cordelia J BarrickDavid W Threadgill
Nov 18, 2006·Journal of Circadian Rhythms·Reade B RobertsDavid W Threadgill
Sep 6, 2011·Cold Spring Harbor Symposia on Quantitative Biology·K M Ramsey, J Bass
Dec 17, 2015·Annual Review of Physiology·Jennifer C JonesPeter J Dempsey
Jun 19, 2008·Annals of the New York Academy of Sciences·Carl D Schlichting
Dec 31, 2008·Genesis : the Journal of Genetics and Development·Tang-Cheng Lee, David W Threadgill
Sep 19, 2008·Growth Factors·Antony W Burgess
Nov 22, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Lawrence A SchevingWilliam E Russell
May 18, 2019·Scientific Reports·Reto EggenschwilerTobias Cantz
Mar 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nianyu LiDario A A Vignali
Nov 4, 2020·ELife·Bryan Marsh, Robert Blelloch
Mar 5, 2016·Cold Spring Harbor Protocols·Karlyne M Reilly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.